Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

0.8261
Delayed Data
As of Aug 18
 -0.0439 / -5.05%
Today’s Change
0.82
Today|||52-Week Range
3.65
-63.28%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close0.87
Today’s open0.87
Day’s range0.82 - 0.87
Volume751,724
Average volume (3 months)835,662
Market cap$85.7M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-43.52%
Earnings growth (this year)+36.56%
Earnings growth (next 5 years)--
Revenue growth (last year)-94.25%
P/E ratioNM
Price/Sales99.52
Price/Book0.78

Competitors

 Today’s
change
Today’s
% change
LPCNLipocine Inc0.000.00%
NTECIntec Pharma Ltd+0.40+6.96%
AGTCApplied Genetic Tech...-0.45-8.57%
AFMDAffimed NV-0.02-1.22%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$1.2M
Annual profit (last year)-$81.8M
Net profit margin-6,853.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, COO &
Director
Joseph P. Hagan
Chief Financial &
Accounting Officer
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts